AMO Pharma Limited
Company 09431909 Active
Connected board network
The connection graph needs a free account.
This company's record is public. The network of who else its directors govern is compiled from the registers by us, and an account keeps it out of bulk scrapers.
Sign in, freeBoard DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
4 directors on the board
- Mcnulty, JR., Martin Doyle Director · appointed 2024
- Snape, Michael Frederick, Dr Director · appointed 2015
- John Bateson Director · appointed 2024
- Alan Louis Rubino Director · appointed 2021
Directors past 6 years
- Snape, Michael Frederick, Dr Director · appointed 2015
First-time vs portfolio directors
First-time (1)
- John Bateson Director · appointed 2024
Portfolio (3)
- Mcnulty, JR., Martin Doyle Director · appointed 2024
- Snape, Michael Frederick, Dr Director · appointed 2015
- Alan Louis Rubino Director · appointed 2021
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Narrow spread of sectors across the board
Where to look Suggested search: directors from a wider range of sectors.
Related organisations iRelated organisationsTwo groups, both deterministic from public records. Related organisations share two or more directors with this board - a real structural link, such as a subsidiary or group company. Connected through a shared director share exactly one person - a genuine connection, but not the same group.
Connected through a shared director
- Yearntree Limited 1 shared director
- Circadian Therapeutics Limited 1 shared director
- AMO-01 Pharma Limited 1 shared director
- AMO-06 Pharma Limited 1 shared director
- Flobiotech Limited 1 shared director
Deterministic, from public records.
Company details
| Number | 09431909 |
| Status | Active |
| Type | Private Limited Company |
| Incorporated | 10/02/2015 |
| Address | 1 PARK ROW, LEEDS, LS1 5AB |
| Accounts next due | 30/09/2026 |
| Accounts last made up | 31/12/2024 |
Industry (SIC)
Ownership - persons with significant control (3)
- Mr Dermot Desmond Irish
significant influence or control - Woodford Patient Capital Trust Plc ceased 2020
ownership of shares 25-50% - Iiu Nominees Limited ceased 2020
significant influence or control
Owns 2 companies iOwnsCompanies where this company is registered as having significant control, from the Companies House PSC (persons with significant control) register.
- AMO-01 Pharma Limited
75-100% shares, 75-100% voting · notified 2021-07-09 - AMO-06 Pharma Limited
75-100% shares, 75-100% voting · notified 2021-07-09
Officers (9)
- Mcnulty, JR., Martin Doyle Director · appointed 2024
- John Bateson Director · appointed 2024
- Alan Louis Rubino Director · appointed 2021
- Snape, Michael Frederick, Dr Director · appointed 2015
Show 5 former officers
- Julia Frances Jones Director · appointed 2021 · resigned 2025
- Joseph Horrigan Director · appointed 2015 · resigned 2025
- Lisa Wittmer Director · appointed 2015 · resigned 2016
- Saiyed Ibraheem Mahmood Director · appointed 2015 · resigned 2024
- Martyn Williams Director · appointed 2015 · resigned 2021
Directors and officers on the Companies House record, current and former.
Report an error in this record - let us know.
Related record